281 |
Inflammatory pathways and coronary heart disease riskFreitag, Daniel Franz January 2014 (has links)
No description available.
|
282 |
Cardiac parameters in young patients with cryptogenic strokeCotter, Paul Eoin January 2014 (has links)
No description available.
|
283 |
The cell surface biochemistry of Erwinia amylovoraRastall, Robert A. January 1989 (has links)
No description available.
|
284 |
Modelling Alzheimer's disease : the impact of genes and dietary manipulations in transgenic micePlucińska, Kaja January 2014 (has links)
No description available.
|
285 |
Development of a Dengue Fever Vaccine from Recombinant DENV2 Protein and Tobacco Mosaic VirusSheih, Tianna 01 January 2016 (has links)
Dengue fever is a rapidly growing concern to human health and is currently the most prevalent mosquito-borne viral disease worldwide. Although there are several vaccine candidates being tested in clinical trials, there are no vaccines publicly available to prevent this disease. Plant-based vaccines are rapidly becoming viable alternatives to traditional animal-based vaccines because they are safe, easy to manufacture, and more cost-efficient. The purpose of this project is to develop a vaccine against the dengue virus by producing a recombinant DENV2 protein, engineered by Dr. David Lo and his lab at University of California Riverside, in Nicotiana benthamiana plants through Tobacco Mosaic Virus (TMV) infection. Initial attempts to ligate the complete DENV2 epitope, a combination of hybrid flagellin sequences and the envelope protein from dengue viral serotype 2, into the pJL TRBO vector were incompatible with established protocols. However, a proof of concept test that replaced the DENV2 envelope protein with Green Fluorescent Protein (GFP) successfully inserted the new sequence into pJL TRBO. In the future, the DENV2 envelope protein sequence will be re-inserted into the construct and updated protocols will be repeated for DENV2 protein expression. The recombinant DENV2 proteins will be extracted from the plants after signs of infection become apparent and tested for their ability to induce an immunogenic response that produces pathogen-specific antibodies.
|
286 |
Effects of estrogen on human catechol-O-methyl transferaseJiang, Hong, 姜紅 January 2001 (has links)
published_or_final_version / Medicine / Doctoral / Doctor of Philosophy
|
287 |
Clinical responses to mechanical periodontal treatment in Chinese patients with actinobacillus actinomycetemcomitans: y Tong Siu Keung, Kenny.Tong, Siu-keung, Kenny., 湯肇強. January 1998 (has links)
published_or_final_version / Dentistry / Master / Master of Dental Surgery
|
288 |
Profile changes of putative periodontal pathogens after non-surgical periodontal treatmentMak, Yun-lok, Raymond., 麥潤樂. January 2002 (has links)
published_or_final_version / Dentistry / Master / Master of Dental Surgery
|
289 |
A study on mitochondrial uncoupling protein 4 (UCP4) in Parkinsonian modelsChu, Chi-yuen, Andrew., 朱志遠. January 2007 (has links)
published_or_final_version / abstract / Medicine / Doctoral / Doctor of Philosophy
|
290 |
Cognitive vulnerability, stress, and postpartum depressive symptomatology: a prospective study in HongKong鍾慧虹, Chung, Wai-hung, Angela. January 2006 (has links)
published_or_final_version / abstract / Clinical Psychology / Master / Master of Social Sciences
|
Page generated in 0.0435 seconds